Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-08-12
1995-09-19
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514278, 514 19, 546 16, 530323, 540543, 540597, A61K 3155, C07D22120
Patent
active
054515785
ABSTRACT:
Compounds of the invention have the formula: ##STR1## which have fibrinogen receptor antagonist activity, including, for example, ##STR2##
REFERENCES:
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5264420 (1993-11-01), Duggan et al.
patent: 5272158 (1993-12-01), Hartman
patent: 5281585 (1994-01-01), Duggan et al.
patent: 5292756 (1994-03-01), Duggan et al.
patent: 5294616 (1994-03-01), Duggan et al.
patent: 5321034 (1994-06-01), Duggan et al.
Baldwin John J.
Claremon David A.
Liverton Nigel
Ivy C. Warren
Merck & Co. , Inc.
Owens Amelia
Parr Richard S.
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1828260